This list is an analysis based on recent market events. It's not an investment recommendation.
About
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
The current price of 461030.KQ is ₩2,345 KRW — it has decreased by -4.09% in the past 24 hours. Watch IMBdx stock price performance more closely on the chart.
What is IMBdx stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange IMBdx stocks are traded under the ticker 461030.KQ.
Is IMBdx stock price growing?▼
461030.KQ stock has fallen by -6.57% compared to the previous week, the month change is a -19.14% fall, over the last year IMBdx has showed a -78.21% decrease.
How many employees does IMBdx have?▼
As of November 3, 2026, the company has 58 employees.